Literature DB >> 18488517

Pay-for-performance programs in P4P programs Israeli sick funds.

Revital Gross1, Asher Elhaynay, Nurit Friedman, Stephen Buetow.   

Abstract

PURPOSE: This paper aims to analyze the development of "pay-for-performance" (P4P) programs implemented by Israel's two largest sick funds, insuring 78 percent of the population. DESIGN/METHODOLOGY/APPROACH: Analysis of the main features and their evolution over time, the observed outcomes and concerns related to implementing these programs.
FINDINGS: Our analysis revealed that although implementation has been successful, both managers and physicians have voiced concerns regarding the effect of measuring clinical performance such as focusing attention on the measured areas while neglecting other areas, and motivating a statistical approach to patient care instead of providing patient-centered care. ORIGINALITY/VALUE: The Israeli case provides an interesting example of nation-wide, long-term implementation of the pay-for-performance program. Therefore, it provides other countries with the opportunity to assess features that may facilitate successful implementation, as well as highlighting issues related to the outcomes of P4P programs.

Entities:  

Mesh:

Year:  2008        PMID: 18488517     DOI: 10.1108/14777260810862380

Source DB:  PubMed          Journal:  J Health Organ Manag        ISSN: 1477-7266


  3 in total

1.  Performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations.

Authors:  Olivier Saint-Lary; Philippe Boisnault; Michel Naiditch; Philippe Szidon; Didier Duhot; Yann Bourgueil; Nathalie Pelletier-Fleury
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

2.  Key issues in the design of pay for performance programs.

Authors:  Frank Eijkenaar
Journal:  Eur J Health Econ       Date:  2011-09-01

3.  A reporting framework for describing and a typology for categorizing and analyzing the designs of health care pay for performance schemes.

Authors:  Yewande Kofoworola Ogundeji; Trevor A Sheldon; Alan Maynard
Journal:  BMC Health Serv Res       Date:  2018-09-04       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.